Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emergence of a Novel SARS-CoV-2 Variant in Southern California
Wenjuan Zhang, Brian Davis, Stephanie S. Chen, et al.
JAMA (2021) Vol. 325, Iss. 13, pp. 1324-1324
Open Access | Times Cited: 373

Showing 1-25 of 373 citing articles:

Features, Evaluation and Treatment Coronavirus (COVID-19)
Marco Cascella, Michael Rajnik, Arturo Cuomo, et al.
StatPearls (2020)
Closed Access | Times Cited: 2803
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Lihong Liu, Sho Iketani, Yicheng Guo, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 676-681
Open Access | Times Cited: 1268
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
Alison Tarke, John Sidney, Nils Methot, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100355-100355
Open Access | Times Cited: 627
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1124-1136.e11
Open Access | Times Cited: 525
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
Xianding Deng, Miguel Garcia-Knight, Mir M. Khalid, et al.
Cell (2021) Vol. 184, Iss. 13, pp. 3426-3437.e8
Open Access | Times Cited: 520
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Tyler N. Starr, Nadine Czudnochowski, Zhuoming Liu, et al.
Nature (2021) Vol. 597, Iss. 7874, pp. 97-102
Open Access | Times Cited: 506
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
Tyler N. Starr, Allison J. Greaney, Adam S. Dingens, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 4, pp. 100255-100255
Open Access | Times Cited: 496
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 408
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Xiaoying Shen, Haili Tang, Charlene McDanal, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 529-539.e3
Open Access | Times Cited: 378
Novel SARS-CoV-2 variants: the pandemics within the pandemic
Erik Boehm, Ilona Kronig, Richard A. Neher, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1109-1117
Open Access | Times Cited: 360
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
Galit Alter, Jingyou Yu, Jinyan Liu, et al.
Nature (2021) Vol. 596, Iss. 7871, pp. 268-272
Open Access | Times Cited: 321
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
Carmen Gómez, Beatriz Perdiguero, Mariano Estéban
Vaccines (2021) Vol. 9, Iss. 3, pp. 243-243
Open Access | Times Cited: 268
On the origin and evolution of SARS-CoV-2
Devika Singh, Soojin V. Yi
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 4, pp. 537-547
Open Access | Times Cited: 261
Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection
Allison J. Greaney, Andrea N. Loes, Lauren E. Gentles, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 600
Open Access | Times Cited: 245
Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)
Abdul Aleem, Abdul Samad, Amy Slenker
(2021) Vol. 01, pp. 01-01
Closed Access | Times Cited: 244
Ongoing global and regional adaptive evolution of SARS-CoV-2
Nash D. Rochman, Yuri I. Wolf, Guilhem Faure, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 29
Open Access | Times Cited: 244
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation
Xianding Deng, Miguel Garcia-Knight, Mir M. Khalid, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 240
Emerging SARS-CoV-2 variants of concern and potential intervention approaches
Jasmin Khateeb, Yuchong Li, Haibo Zhang
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 229
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351
Xiaoying Shen, Haili Tang, Rolando Pajón, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 24, pp. 2352-2354
Open Access | Times Cited: 219
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
Richard Copin, Alina Baum, Elzbieta Wloga, et al.
Cell (2021) Vol. 184, Iss. 15, pp. 3949-3961.e11
Open Access | Times Cited: 213
Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries
Rui Wang, Jiahui Chen, Kaifu Gao, et al.
Genomics (2021) Vol. 113, Iss. 4, pp. 2158-2170
Open Access | Times Cited: 198
Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike
Bailey Lubinski, Maureen Hoch Vieira Fernandes, Laura E. Frazier, et al.
iScience (2021) Vol. 25, Iss. 1, pp. 103589-103589
Open Access | Times Cited: 194
The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
Dandan Tian, Yanhong Sun, Jianming Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 192
Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know?
Deepa Vasireddy, Rachana Vanaparthy, Gisha Mohan, et al.
Journal of Clinical Medicine Research (2021) Vol. 13, Iss. 6, pp. 317-325
Open Access | Times Cited: 185
SARS-CoV-2 Mutations and their Viral Variants
Begüm Coşar, Zeynep Yağmur KARAGÜLLEOĞLU, Sinan ÜNAL, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 63, pp. 10-22
Open Access | Times Cited: 184
Page 1 - Next Page

Scroll to top